Despite advancements in cancer therapies, testing is performed inside a patient’s body with no lab standard to determine which treatment will work best. Sanatela Medical is helping doctors get closer to individualized cancer treatment and a pathway to a cure with the Sanatela Matrix, the first matrix that comes from decellularized Wharton’s jelly to mimic the micro environment of the human body. Sanatela Medical Co-Founder and Executive Vice President, Erin Crowley, shares how her company is advancing the treatment of leukemia and other cancers, with the potential to move into applications like skin and hair regeneration and veterinary therapies.
Learn more about Sanatela Medical and their breakthrough medical technology at sanatelamedical.com.
